Yan M, Sun J, Bird P I, Liu D L, Grigg M, Lim Y L
Department of Cardiology, Box Hill Hospital, Australia.
Life Sci. 2001 Jan 26;68(10):1191-8. doi: 10.1016/s0024-3205(00)01027-4.
In this study we analyzed the different alpha1-adrenoceptor (AR) subtypes present in human saphenous vein (HSV) using reverse transcription polymerase chain reaction (RT-PCR), DNA-DNA hybridization analysis and functional affinities for alpha-AR antagonists. DNA-DNA hybridization analysis of RT-PCR amplification products confirmed the presence of alpha1A- and alpha1B-ARs, and low levels of alpha1D-AR in HSV. The functional results showed: (1) prazosin, the selective alpha1-AR antagonist, phentolamine, the alpha1- and alpha2-ARs antagonist, WB 4101 and 5-MU, the selective alpha1A-AR subtype antagonists were potent, competitive antagonists of noradrenaline (NA)-induced contraction (pA2 values of 11.03, 8.06, 9.02 and 8.34, respectively). (2) Alpha1-AR-induced contraction was sensitive to the alkylating effects of CEC (the alpha1B and alpha1D-AR subtypes antagonist) and (3) The selective alpha1D-AR subtype antagonist BMY displayed low affinity (pA2 values of 6.44). This indicates that the contractile response of the HSV to alpha1-AR-induced is predominantly mediated by both alpha1A and alpha1B-AR subtypes. This was also supported by the good relationship between pA2 values from the present study and reported binding affinities (pKi) values of various alpha1-AR subtype antagonists with cloned human alpha1A- and alpha1B-AR subtypes (r=0.89 and r=0.98, respectively), but not the alpha1D-AR subtype (r=0.67). Our results indicate that alpha1A- and alpha1B-ARs are the main functional and expressed receptor subtypes in HSV.
在本研究中,我们使用逆转录聚合酶链反应(RT-PCR)、DNA-DNA杂交分析以及α-肾上腺素能受体(AR)拮抗剂的功能亲和力,分析了人隐静脉(HSV)中存在的不同α1-肾上腺素能受体亚型。对RT-PCR扩增产物的DNA-DNA杂交分析证实了HSV中存在α1A-和α1B-肾上腺素能受体,以及低水平的α1D-肾上腺素能受体。功能研究结果显示:(1)选择性α1-肾上腺素能受体拮抗剂哌唑嗪、α1-和α2-肾上腺素能受体拮抗剂酚妥拉明、选择性α1A-肾上腺素能受体亚型拮抗剂WB 4101和5-MU,均为去甲肾上腺素(NA)诱导收缩的强效竞争性拮抗剂(pA2值分别为11.03、8.06、9.02和8.34)。(2)α1-肾上腺素能受体诱导的收缩对CEC(α1B和α1D-肾上腺素能受体亚型拮抗剂)的烷基化作用敏感,并且(3)选择性α1D-肾上腺素能受体亚型拮抗剂BMY显示出低亲和力(pA2值为6.44)。这表明HSV对α1-肾上腺素能受体诱导的收缩反应主要由α1A和α1B-肾上腺素能受体亚型介导。本研究的pA2值与报道的各种α1-肾上腺素能受体亚型拮抗剂与克隆的人α1A-和α1B-肾上腺素能受体亚型的结合亲和力(pKi)值之间的良好关系(分别为r=0.89和r=0.98)也支持了这一点,但与α1D-肾上腺素能受体亚型无关(r=0.67)。我们的结果表明,α1A-和α1B-肾上腺素能受体是HSV中主要的功能性和表达性受体亚型。